Company profile
BioTech Medics, Inc.
OTC: BMCS · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ market scale, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
—
as of 2026-08-28
Market cap
$20.5k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BioTech Medics, Inc.’s financial profile?
BioTech Medics, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Psykey, Inc.——Vincerx Pharma, Inc.——Psyence Biomedical Ltd.——Adastra Holdings Ltd.——North Springs Resources Corp——Hemp Naturals, Inc.——Neighbors
Tarrant →Key facts
CEOAnthony Keith Miller
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSouthlake, TX
ExchangeOTC: BMCS
Employees—
IPO date2010-07-23
Latest filings
No filings loaded.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.